This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring trifluoromethyl groups and a thioxomethylamino moiety, makes it a valuable intermediate in creating molecules with potential therapeutic effects. It has been explored in the design of enzyme inhibitors, especially those targeting proteases or kinases, which are relevant in treating diseases like cancer, inflammation, and viral infections. Additionally, its unique chemical framework allows for modifications to enhance bioavailability and selectivity, making it a promising scaffold in medicinal chemistry. Researchers also investigate its role in optimizing pharmacokinetic properties of drug molecules, such as metabolic stability and membrane permeability.